Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors

Anderson KG, Ribas A. Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors. J Immunother Cancer. 2025 Aug 25;13(8):e013061. doi: 10.1136/jitc-2025-013061. PMID: 40854816.


Related Posts